Description
Book SynopsisTable of ContentsPreface Marc E. Lavoie and Andrea E. Cavanna 1. The genetic basis of Gilles de la Tourette syndrome Sarah B. Abdallah, Evan Realbuto, Mary Oluwatosin Kaka, Kelly Yang, Apostolia Topaloudi, Peristera Paschou, Jeremiah M. Scharf and Thomas V. Fernandez 2. Studying the pathophysiology of tic disorders in animal models Christopher Pittenger 3. The neural-immune crosstalk in Tourette syndrome: From immunobiology to epistemology Yasamin Mahjoub, Davide Martino and Andrea E. Cavanna 4. Functional connectivity in the Gilles de la Tourette syndrome Matthew Feigelis and Deanna J. Greene 5. Perception-action integration in Gilles de la Tourette syndrome Theresa Paulus, Christian Beste and Alexander Münchau 6. The pharmacological treatment of Tourette syndrome José Fidel Baizabal-Carvallo and Joseph Jankovic 7. Ecopipam: A D1 receptor antagonist for the treatment of Tourette syndrome Richard E. Chipkin, Donald L. Gilbert and Atul Mahableshwarkar 8. Atypical antipsychotics for treatment of Tourette syndrome Vamsi K. Kalari, Peter E. Morrison and Cathy L. Budman 9. Alpha agonists for the treatment of Tourette syndrome Nick Cothros and Tamara Pringsheim 10. Cannabinoids: Possible role in the pathophysiology and therapy of Gilles de la Tourette syndrome Natalia Szejko and Kirsten Müller-Vahl 11. Novel potential avenues for the therapy of Tourette syndrome: Cannabinoid and steroid-based tools Marco Bortolato and Roberto Cadeddu 12. Non-invasive brain stimulation for the treatment of Tourette's syndrome Sneha Chenji, Kayla D. Stone and Frank P. MacMaster 13. Entrainment of movement-related brain oscillations to improve symptoms in Tourette syndrome Mairi Houlgreave, Bàrbara Morera Maiquez, Katherine Dyke, Georgina Jackson and Stephen Jackson 14. Network oscillatory activity in chronic tics and Tourette syndrome Joohi Jimenez-Shahed
